NASDAQ:SCPS

Scopus Biopharma Stock Insider Trading

etoro logo Buy SCPS
*Your capital is at risk
$0.0004
+0 (+0%)
At Close: Jun 22, 2026

Scopus BioPharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 5.36M and sold 12M SCPS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 5.36M shares
Sell 12M shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 200
Value: $2K
Feb 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 300
Value: $12.6K
Feb 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Lamstein Joshua R
Chairman
CEO / President 500
Value: $5K
Feb 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 200
Value: $2K
Feb 23, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 1 300
Value: $12.6K
Feb 22, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Lamstein Joshua R
Chairman
CEO / President 100
Value: $999
Feb 22, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 450
Value: $5K
Feb 22, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Lamstein Joshua R
Chairman
CEO / President 100
Value: $999
Feb 22, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 450
Value: $5K
Feb 19, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Lamstein Joshua R
Chairman
CEO / President 500
Value: $5K
Feb 19, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Lamstein Joshua R
Chairman
CEO / President 500
Value: $5K
Feb 18, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 2 200
Value: $22.1K
Feb 18, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 2 200
Value: $22.1K
Feb 17, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 475
Value: $5K
Feb 17, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 200
Value: $2K
Feb 17, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 475
Value: $5K
Feb 17, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 200
Value: $2K
Feb 16, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 2 500
Value: $25.5K
Feb 16, 2021
Buy
Common Stock, par value $0.001
P-Purchase
Greenspan Ira Scott
Executive Committee Chairman
CEO / President 2 500
Value: $25.5K
Dec 16, 2020
Buy
Common Stock, par value $0.001
Buckel David A.
Director
Director 0
Value: $0
Dec 16, 2020
Buy
Common Stock, par value $0.001
Buckel David A.
Director
Director 0
Value: $0
Dec 15, 2020
Buy
Common Stock
Hopper Paul
Director
Director 0
Value: $0
Dec 15, 2020
Buy
Common Stock
Hopper Paul
Director
Director 0
Value: $0
Dec 15, 2020
Buy
Common Stock
Hopper Paul
Director
Director 0
Value: $0
Dec 15, 2020
Buy
Common Stock
Hopper Paul
Director
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SCOPUS BIOPHARMA INC.
Scopus BioPharma
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) inhibitors; and MRI-1867, rationally designed, orally available, dual-action, hybrid, and small molecule...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.29% Jun 10
PHM
$118.49
6.02% Jun 10
EAT
$140.46
17.09% Jun 05
E
ETD
$20.67
3.19% Jun 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE